
To help keep our community authentic, we're showing information about accounts on Linktree.
Mainstay Medical has been a member of Linktree for 2 years and joined in February 2024. The social media accounts linked to from Mainstay Medical are: Facebook, Instagram, LinkedIn, X. Besides social media accounts, reactiv8restorative has populated their site with 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗠𝗮𝗰𝗸'𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, Register: Happy Hour Launch Regenerative Medicine Division of ASPN, APTA Orthopedics Virtual Conference 2026, Educational Webinar: What Your MRI Is Telling You: Why Multifidus Dysfunction Changes How We Think About CLBP, Register: Patient Education Webinar – Dr. Kathryn Schott, Register: ISASS Webinar — Multifidus Dysfunction in Spine Surgery, ReActiv8 Patient Mentor Program, New Publication: 5-Year Longitudinal Follow-up, REGISTER HERE: PSPS 2025 - Get ReActiv8 Certified - Live in Las Vegas!, Careers - Mainstay Medical, MassDevice - How to design medtech clinical trials that deliver, For Military, New Publication: Restorative Neurostimulation of the Lumbar Multifidus Muscles, Let’s Connect at ASPN – Tap to Sign Up, MUSC Novel Pain Treatment Gives Patient New Lease on Life, Best Exercises to Keep Your Back Strong and Pain-Free, Multifidus Dysfunction: Diagnosis, Recovery & Treatment, PR - Mainstay Medical Announces Exclusive Coverage of ReActiv8 by Blue Cross Blue Shield of North Dakota, ISSLS Prize in Basic Science 2025: Structural changes of muscle spindles in the multifidus muscle after intervertebral disk injury are resolved by targeted activation of the muscle - European Spine Journal, Virtual Education Seminar — Sure Med Compliance, The Multifidus: The Missing Link in Low Back Pain - Healthcare Revolution, Jason Hannon, CEO of Mainstay Medical, Doctors Unscripted Podcast, PR - Mainstay Medical Announces Exclusive Coverage of ReActiv8 by Anthem Blue Cross/Blue Shield, Pros and Cons of RFA in Treating Chronic Low Back Pain, Register: RESTORE Data Reveal Webinar, New Publication: Restorative Neurostimulation for Patients with Mechanical Chronic Low Back Pain and Impaired Neuromuscular Control of the Lumbar Spine, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗝𝗶𝗺'𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, WEBINAR Understanding the Importance of Radiology in Identifying Multifidus Dysfunction for Treatm, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗥𝗮𝗰𝗵𝗲𝗹’𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, New Publication: Multifidus Dysfunction and Chronic Low Back Pain: Systematic Review and Meta-analysis of the Supporting Data for Accurate Diagnosis and Successful Treatment Outcomes Associated With Restorative Neurostimulation | International Journal of, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗝𝘂𝗱𝘆’𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗞𝗮𝗿𝗹’𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, Twitter, Debunking 7 Common Myths About Back Pain Prevention, The Journey to Commercial Coverage, Becker’s Spine Review: Anthem Blue Cross and Blue Shield to cover restorative neurostimulation, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗟𝗮𝘂𝗿𝗮’𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗟𝘂𝗹𝘂'𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗕𝗿𝗶𝗮𝗻𝗻𝗮'𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗝𝘂𝗱𝘆’𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗛𝗲𝗻𝗿𝘆’𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 — 𝗝𝗲𝘀𝘀𝗶𝗰𝗮’𝘀 𝗥𝗲𝗔𝗰𝘁𝗶𝘃𝟴 𝗝𝗼𝘂𝗿𝗻𝗲𝘆, Becker's Spine Review: Spine group lauds new ICD-10 back pain code, ReActiv8 Patient Testimonials, ReActiv8 Patient Jolee Camp on Stark 4 News, Noridian - Medicare Billing and Coding Guidelines for ReActiv8, ReActiv8 Patient Education Webinar, Barts Health NHS Trust - Patients Benefit from New Nack Pain Treatment -, PR - Mainstay Medical Announces Positive Outcomes from Landmark RESTORE Clinical Trial of ReActiv8, PR - ReActiv8-B 5-Year Data, For Physical Therapist, For Physicians, For Patients, Outcomes Rocket - Treating the Cause, Not the Symptoms, PR - Mainstay Medical Announces Coverage Recommendation from the International Society for the Advancement of Spine Surgery (ISASS) for ReActiv8, The Pain Unfiltered Podcast, PR - Mainstay Medical Announces New ICD-10 Diagnosis Code for Multifidus Dysfunction, PR - FDA Approval for MRI Labeling on ReActiv8, PR - Mainstay Medical Announces Receipt of European and Australian Approvals of MRI Labeling on ReActiv8 Restorative Neurostimulation System, PR - Mainstay Medical Announces Publication of the First Neuromodulation Study for Low Back Pain with 5-Year Follow-Up, PR - Mainstay Medical Announces Publication of Clinical Results Comparing Older Patients and Younger Patients, PR - Mainstay Medical Announces US$125 Million Equity Financing Transaction.